A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
Saved in:
| Title: | A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research. |
|---|---|
| Authors: | Yaden DB; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Graziosi M; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Clinical Psychology, Hofstra University, Hempstead, New York, USA., Owen AM; Smith College School for Social Work, Northampton, Massachusetts, USA., Agin-Liebes G; Department of Psychiatry, University of California, San Francisco, California, USA.; Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Towson, Maryland, USA., Aaronson ST; University of Maryland School of Medicine, Baltimore, Maryland, USA.; University of Arizona, Tucson, Arizona, USA., Allen KE; Department of Psychological & Brain Sciences, Krieger School of Arts & Sciences, Johns Hopkins University, Baltimore, Maryland, USA., Barrett FS; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Psychiatry, NYU Langone Center for Psychedelic Medicine, NYU Grossman School of Medicine, New York, New York, USA., Bogenschutz MP; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Carhart-Harris R; Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Towson, Maryland, USA., Ching THW; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA., Cosimano MP; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Danforth A; The Lundquist Institute at the Harbor-UCLA Medical Center, Torrance, California, USA., Davis AK; Center for Psychedelic Drug Research and Education, College of Social Work, The Ohio State University, Columbus, Ohio, USA.; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Garcia-Romeu A; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Griffiths R; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Grob CS; The Lundquist Institute at the Harbor-UCLA Medical Center, Torrance, California, USA., Gründer G; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; German Center for Mental Health (DZPG), Partner Site Mannheim, Mannheim, Germany., Gukasyan N; New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, USA., Heinzerling KG; Treatment and Research In Psychedelics (TRIP) Center, Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, California, USA., Hendricks PS; Department of Psychiatry and Behavioral Neurobiology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Holze F; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Horton DM; Department of Family Medicine and Community Health, University of Wisconsin, Madison, Wisconsin, USA., Johnson MW; Center of Excellence for Psilocybin Research and Treatment, Sheppard Pratt, Townson, Maryland, USA.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Kelmendi B; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA., Knatz Peck S; Department of Psychiatry, University of California San Diego, San Diego, California, USA., Koslowski M; Department of Psychiatry and Psychotherapy, Charité CCM-Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Iméra Institute of Advanced Studies, Aix Marseille University, Marseille, France., Liechti ME; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Mertens LJ; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; German Center for Mental Health (DZPG), Partner Site Mannheim, Mannheim, Germany., Moreno FA; College of Medicine Tucson, University of Arizona, Tucson, Arizona, USA., Nayak SM; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Nicholas CR; Department of Family Medicine and Community Health, University of Wisconsin, Madison, Wisconsin, USA., Preller KH; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Rieser NM; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Ross S; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Sergi K; Treatment and Research In Psychedelics (TRIP) Center, Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, California, USA., Sloshower J; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA., Smigielski L; Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Stenbæk DS; Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Denmark.; Department of Psychology, Copenhagen University Clinic for Psychedelic Research, University of Copenhagen, Copenhagen, Denmark., Vollenweider FX; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Weiss B; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Wolff M; MIND Foundation gGmbH, Berlin, Germany.; Department of Psychiatry and Psychotherapy, Charité CCM-Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Yaden ME; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |
| Source: | Psychedelic medicine (New Rochelle, N.Y.) [Psychedelic Med (New Rochelle)] 2025 Feb 27; Vol. 3 (1), pp. 1-18. Date of Electronic Publication: 2025 Feb 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mary Ann Liebert Inc Country of Publication: United States NLM ID: 9918610585506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2831-4433 (Electronic) Linking ISSN: 28314425 NLM ISO Abbreviation: Psychedelic Med (New Rochelle) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
